Skip to main content

STAAR SURGICAL CO

For the period ended Dec 27, 2024. Filed Feb 21, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

STAA$24.55-2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Operations

(In thousands, except per share amounts)

202420232022
Net sales$313,901$322,415$284,391
Cost of sales74,31969,76461,008
Gross profit239,582252,651223,383
Selling, general and administrative expenses:
General and administrative89,89872,31954,742
Selling and marketing108,322107,83488,856
Research and development53,97344,40135,983
Total selling, general and administrative expenses252,193224,554179,581
Operating income (loss)(12,611)28,09743,802
Other income, net:
Interest income, net5,9116,9862,448
Loss on foreign currency transactions(3,675)(1,909)(1,707)
Royalty income50874804
Other income, net815448205
Total other income, net3,5595,5991,750
Income (loss) before income taxes(9,052)33,69645,552
Provision for income taxes11,15612,3495,887
Net income (loss)$(20,208)$21,347$39,665
Net income (loss) per share:
Basic$(0.41)$0.44$0.83
Diluted$(0.41)$0.43$0.80
Weighted average shares outstanding:
Basic49,12548,52347,987
Diluted49,12549,42749,380
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.